Temsirolimus, sold under the brand name?Torisel, is an intravenous drug for the treatment of?renal cell carcinoma?(RCC), developed by?Wyeth?Pharmaceuticals and approved by the U.S.?Food and Drug Administration?(FDA) in May 2007,[3]?and was also approved by the?European Medicines Agency?(EMA) in November 2007.[1]?It is a derivative and prodrug of?sirolimus.
Share ThisFacebookTwitterWhatsAppPinterestShare This